VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | Immunotherapy for myeloma: past, present, future

VJHemOnc is committed to improving our service to you

Hermann Einsele

Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany, discusses the use of immunomodulatory therapies in multiple myeloma (MM), including monoclonal antibodies and checkpoint inhibitors. Prof. Einsele gives us an overview of the progress that has been made in the treatment of MM, as well as looking towards the future of immunotherapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter